摘要 : Background Dotinurad is a novel, selective urate reabsorption inhibitor, which reduces serum uric acid levels by selective inhibition of the urate transporter 1. We evaluated the efficacy and safety of dotinurad versus febuxostat,... 展开
作者 | Hosoya~ Tatsuo Furuno~ Kazuki Kanda~ Shingo |
---|---|
作者单位 | |
期刊名称 | 《Clinical and experimental nephrology 》 |
总页数 | 9 |
语种/中图分类号 | 英语 / R69 |
关键词 | Hyperuricemia Gout Selective urate reabsorption inhibitor (SURI) URAT1 inhibitor Dotinurad Febuxostat |
馆藏号 | N2007EPST0002083 |